ReviewClinical pharmacokinetics2023

Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis.

Terra M Kruger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.